We are live on ! Find out more
RB

Richmond Brothers Portfolio holdings

AUM $150M
1-Year Est. Return 14.02%
This Fund
S&P 500
This Quarter Est. Return
+16.66%
1 Year Est. Return
+14.02%
3 Year Est. Return
+102.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$59.3M
AUM Growth
-$12M
Cap. Flow
-$21.8M
Cap. Flow %
-36.71%
Top 10 Hldgs %
92.65%
Holding
22
New
1
Increased
1
Reduced
20
Closed
–

Top Buys

Rank Stock Value
1
IRD
Opus Genetics
IRD
+$41.5K
2
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
+$37.7K

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$7.64M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.86M
3
AAPL icon
Apple
AAPL
+$2.33M
4
GOF icon
Guggenheim Strategic Opportunities Fund
GOF
+$2.06M
5
MDXG icon
MiMedx Group
MDXG
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 17.56%
2 Healthcare 14.16%
3 Financials 11.56%
4 Communication Services 1.66%
5 Consumer Discretionary 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
Invesco QQQ Trust
QQQ
$453B
$19.9M 33.56%
61,969
-25,881
-29% -$7.64M
AAPL icon
2
Apple
AAPL
$4.54T
$8.15M 13.76%
49,439
-15,775
-24% -$2.33M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.1T
$6.85M 11.56%
22,179
-12,532
-36% -$3.86M
MDXG icon
4
MiMedx Group
MDXG
$602M
$5.98M 10.1%
1,755,127
-461,693
-21% -$1.79M
GOF icon
5
Guggenheim Strategic Opportunities Fund
GOF
$2.23B
$5.15M 8.7%
318,696
-124,886
-28% -$2.06M
ARKK icon
6
ARK Innovation ETF
ARKK
$5.64B
$2.36M 3.99%
58,554
-11,371
-16% -$436K
MSFT icon
7
Microsoft
MSFT
$3.45T
$2.25M 3.8%
7,811
-1,937
-20% -$494K
IBB icon
8
iShares Biotechnology ETF
IBB
$9.34B
$2.16M 3.64%
16,724
-13,261
-44% -$1.74M
IRD
9
Opus Genetics
IRD
$306M
$1.28M 2.15%
340,526
+11,556
+4% +$41.5K
RMTI icon
10
Rockwell Medical
RMTI
$28.4M
$825K 1.39%
45,594
-11,143
-20% -$192K
NVG icon
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$786K 1.33%
66,732
-38,144
-36% -$458K
AIRI icon
12
Air Industries Group
AIRI
$13M
$514K 0.87%
135,019
-5,051
-4% -$23.9K
MCD icon
13
McDonald's
MCD
$192B
$455K 0.77%
1,629
-282
-15% -$75.6K
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.36T
$408K 0.69%
3,920
-1,846
-32% -$178K
AMZN icon
15
Amazon
AMZN
$2.92T
$401K 0.68%
3,886
-826
-18% -$79.8K
IVV icon
16
iShares Core S&P 500 ETF
IVV
$878B
$376K 0.63%
915
-159
-15% -$63.7K
VZ icon
17
Verizon
VZ
$195B
$361K 0.61%
9,288
-3,365
-27% -$133K
PG icon
18
Procter & Gamble
PG
$336B
$278K 0.47%
1,867
-172
-8% -$24.6K
JNJ icon
19
Johnson & Johnson
JNJ
$618B
$272K 0.46%
1,753
-228
-12% -$36.8K
SPLV icon
20
Invesco S&P 500 Low Volatility ETF
SPLV
$7.12B
$259K 0.44%
4,143
-2,264
-35% -$141K
T icon
21
AT&T
T
$159B
$218K 0.37%
11,300
-4,595
-29% -$87.8K
ONCT
22
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$30.1K 0.05%
+1,918
New +$37.7K

Similar funds

CRIG
Charter Research & Investment Group Southport, Connecticut $150M AUM 28.05% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM

Richmond Brothers's Q1 2023 Portfolio in Review

As of Q1 2023, Richmond Brothers held 22 positions worth $59.3M, down 17% from $71.3M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Richmond Brothers withdrew a net $21.8M in Q1 2023, reducing 20 holdings. Its largest reduction was Invesco QQQ Trust, cutting an estimated $7.64M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Richmond Brothers opened a new position in Oncternal Therapeutics, Inc. Common Stock worth $30.1K.

  • Richmond Brothers's largest Q1 2023 buy was Oncternal Therapeutics, Inc. Common Stock: 1,918 shares worth $30.1K.
  • Richmond Brothers added most to Opus Genetics in Q1 2023, an estimated $41.5K increase.
  • Richmond Brothers's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $7.64M.
  • Richmond Brothers's ten largest holdings make up 93% of its $59.3M portfolio in Q1 2023.
  • Richmond Brothers opened 1 new position and closed 0 in Q1 2023.
  • Richmond Brothers's portfolio value fell 17% quarter-over-quarter to $59.3M.

Based on Richmond Brothers's 13F filing for Q1 2023, filed 10 May 2023.